Vertex Pharma Obtains Exclusive License To TreeFrog’s Cell Manufacturing Technology, C-Stem
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Vertex Pharmaceuticals Inc. (VRTX) announced Tuesday that it has obtained an exclusive license from TreeFrog Therapeutics, a French-based biotech company, to its proprietary cell manufacturing technology, C-Stem, to optimize production of Vertex’s cell therapies for t
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1383931917-16f7e81b08344140b4041462de226112.jpg "The 6 Best Online Banks for May 2024")
